Skip to main content
. 2021 Aug 19;27:91. doi: 10.1186/s10020-021-00355-7

Fig. 4.

Fig. 4

The effects of hucMSC on METTL14 overexpression on HNPC are inhibited by miR-26a-5p inhibitor. A Cell viability, B LDH activity, C, D pyroptosis, EG expression of METTL14, NLRP3, caspase-1, and GSDMD-N, and H content of IL-1β and IL-18 were measured in D-HNPC transduced with the METTL14 expression vector and treated with hucMSC-exo from hucMSC transfected with miR-26a-5p inhibitor (hucMSC/inhibitor-exo) or NC (hucMSC/NC-exo). ***P < 0.001